Evolving Models of HIV CareVolume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box
Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial.
Amanyire G, et al. Lancet HIV. 2016;3(11):e539-e548.
Cohen MS, et al. N Engl J Med. 2016;375(9):830-839.
Cohen MS, et al. N Engl J Med. 2011;365(6):493-505.
Colasanti J. 25th Conference on Retroviruses and Opportunistic Infections (CROI) 2018. March 4−7, 2018; Boston, MA. Poster 1109.
Continuous retention and viral suppression provide further insights into the HIV care continuum compared to the cross-sectional HIV care cascade.
Colasanti J, et al. Clin Infect Dis. 2016;62(5):648-654.
Linkage and antiretroviral therapy within 72 hours at a federally qualified health center in New Orleans.
Halperin J, et al. AIDS Patient Care STDS. 2018;32(2):39-41.
Schoen J, et al. Healio Infectious Disease News. 2018.
INSIGHT START Study Group. N Engl J Med. 2015;373(9):795-807.
Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: a randomized unblinded trial.
Koenig S, et al. PLoS Med. 2017;14(7):e1002357.
Effect of offering same-day ART vs usual health facility referral during home-based HIV testing on linkage to care and viral suppression among adults with HIV in Lesotho: the CASCADE randomized clinical trial.
Labhardt ND, et al. JAMA. 2018;319(11):1103-1112.
Association of implementation of a universal testing and treatment intervention with HIV diagnosis, receipt of antiretroviral therapy, and viral suppression in East Africa.
Peterson M, et al. JAMA. 2017;317(21):2196-2206.
The effect of same-day observed initiation of antiretroviral therapy on HIV viral load and treatment outcomes in a U.S. public health setting.
Pilcher CD, et al. J Acquir Immune Defic Syndr. 2017;74(1):44-51.
Initiating antiretroviral therapy for HIV at a patient’s first clinic visit: the RapIT randomized controlled trial.
Rosen S et al. PLoS Med. 2016;13(5):e1002015.
Scheer S, et al. Clin Infect Dis. 2018;66(7):1027-1034.
TEMPRANO ANRS 12136 Study Group. N Engl J Med. 2015;373(9):808-822.
White KL, et al. 25th Conference on Retroviruses and Opportunistic Infections (CROI), 2018. March 4−7, 2018; Boston, MA Abstract 532.
Are We Now in an Integrase-Based World?
Evaluating Switching Strategies of Today and Tomorrow
Evolving Models of HIV Care (Volume 1) - Rapid ART Initiation: A New Addition to the HIV-Care Tool Box
The PCPs Role in Preventing HIV
What Do You Know About PrEP?
Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care
What Do You Know About PrEP?
Got it? Treat it!
The Critical Role of the Community Pharmacist
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.
Key Issues Impacting OB/GYN Practice
Hot Topics in HBV, HCV, and NASH
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Why It Matters in OB/GYN Practice Today
A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities
How the Pharmacist Can Make a Difference
HIV Can Be Prevented— Are You Doing Your Part?
Rapid Start ART — A New Model for HIV Care
Understanding the Growing Syndemic — Opioids, HCV, and HIV
A PrEP Primer
The PCP’s Role in HCV Elimination
What the Pharmacist Needs to Know about PrEP
Maximizing Your Role to Impact Patient Outcomes
Benefits, Barriers, & Best Practices in an Advancing Field